Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
adverse drug reaction
age associated memory impairment
aggression
agitation
algorithm
Alzheimer's disease
Alzheimer's disease, diagnosis of
Alzheimer's disease, driving with
Alzheimer's disease, early symptoms
Alzheimer's disease, patient awareness of
Alzheimer's disease, preclinical
Alzheimer's disease, prognosis of
Alzheimer's disease, risk factors in
Alzheimer's disease, telling patient diagnosis of
Alzheimer's disease, treatment of
amyloid beta protein
anosognosia
anticholinesterase
anticoagulant, treatment
antidepressant
antiphospholipid antibodies
anxiety
atypical
behavior
behavior, combative
behavioral disorder
biologic markers
carbamazepine
caregiver
CAT scan, abnormal
CAT scan, emission
CAT scan, emission, abnormal
CAT scan, venography
cerebral venous infarction
cerebral venous thrombosis
cerebral venous thrombosis, deep
cerebral venous thrombosis, etiology
cerebral venous thrombosis, recurrent
cerebrospinal fluid
cerebrospinal fluid, abnormal
cerebrovascular accident
cerebrovascular accident, acute management of
cerebrovascular accident, prevention of
cerebrovascular accident, thrombolytic agents in treatment
children
complications
controversies in neurology
craniectomy, decompressive
D-dimer
degenerative diseases of CNS
dementia
dementia, diagnostic evaluation of
dementia, driving with
dementia, early detection
dementia, preexisting in stroke patient
dementia, screening for
dementia, treatment of
donepezil
driving
driving restrictions
driving test
dural sinus thrombosis
dying
efficacy
endovascular therapy
epidemiology of neurology
ethics in neurology
evidence-based research
exercise
Factor V Leiden
fibrinolytic agents
fibrinolytic agents, intra-venous local infusion
gadolinium
galantamine
headache
hydrocephalus
incidence
intellectual deficit
intracranial pressure, increased
level of consciousness, decreased
medical-legal aspects of neurology
memory
memory, impairment of
memory, impairment of, subjective
mild cognitive impairment
mild cognitive impairment converting to Alzheimer's disease
Mini Mental Status Examination
mortality
MRI
MRI, abnormal
MRI, CAT scan compared to
MRI, contrast enhanced
MRI, venography
neuroleptic
neuroleptic, atypical
neurologic complications of, systemic disease
neurologic disease, diagnoses of
neurologic examination, focal
neurologic symptoms
olanzapine
old age, driving and
old age, neurology of
oral contraceptives
patient information and support
pitfalls
practice guidelines
preclinical
pregnancy, neurologic complications in
prethrombotic state
prognosis
protein C deficiency
protein S deficiency
psychological testing
psychosis
psychotic behavior
quetiapine
review article
risk factors
risk factors, modification
risperidone
rivastigmine
safety
seizure
selective serotonin reuptake inhibitors
suicide
tissue plasminogen activator, intravenous
treatment of neurologic disorder
white matter disease
workup
Showing articles 700 to 750 of 1454 << Previous Next >>

Protocol Violations in Community-Based rTPA Stroke Treatment Are Associated with Symptomatic Intracerebral Hemorrhage
Stroke 32:12-16, Lopez-Yunez,A.M.,et al, 2001

Pathological Correlates of Late-Onset Dementia in a Multicentre, Community-based Population in England and Wales
Lancet 357:169-175, Neuroapthology Group of the Medical Research Counc, 2001

Risk Factors for Sever Hemorrhagic Transformation in Ischemic Stroke Patients Treated with Recombinant Tissue Plasminogen Activator
Stroke 32:438-441, Larrue,V.,et al, 2001

Effect of Donepezil on Brain Acetylcholineserase Activity in Patients with AD Measured by PET
Neurol 56:408-410, Shinotoh,H.,et al, 2001

Deterioration Following Improvement with tPA Therapy: Carotid Thrombosis and Reocclusion
Neurol 56:568-570, Burgin,W.S. &Alexandrov,A.V., 2001

Use of Specialized Coagulation Testing in the Evaluation of Patients with Acute Ischemic Stroke
Neurol 56:624-627, Bushnell,C.,et al, 2001

Magnetic Resonance Spectroscopy in AD
Neurol 56:592-598, Valenzuela,M.J.,et al, 2001

Age-Related Memory Decline
Arch Neurol 58:360-364, Small,S.A., 2001

Evaluation of CSf-tau and CSF-AB42 as Diagnostic Markers for Alzheimer Disease in Clinical Practice
Arch Neurol 58:373-379,349, Andreasen,N.,et al, 2001

Hormone Replacement Therapy and Cognition
JAMA 285:1489-1499, LeBlanc,E.S.,et al, 2001

Evidence Based Medicine: Concerns of a Clinical Neurologist
JNNP 71:569-576, Caplan,L.R., 2001

Systematic Review of Immunomodulatory Drugs for the Treatment of People with Multiple Sclerosis: Is There Good Quality Evidence on Effectiveness and Cost?
JNNP 70:574-579, Bryan,J.,et al, 2001

The Expanding Spectrum of Herpesvirus Infections of the Nervous System
Brain Pathology 11:440-451, Kleinschmidt-DeMasters,B.K. &Gilden,D.H., 2001

The Effect of Brain Atrophy on Cerebral Hypometabolism in the Visual Variant of Alzheimer Disease
Arch Neurol 58:480-486, Bokde,A.L.W.,et al, 2001

Magnetic Resonance Imaging of Cerebral Microbleeds
Current Opinion in Neurology 13:69-73, Roob,G.&Fazekas,F., 2000

Practice Parameter: Risk of Driving and Alzheimer's Disease (An Evidence-Based Review)
Neurol 54:2205-2211, Dubinsky,R.M.,et al, 2000

The Preclinical Phase of Alzheimer Disease
Arch Neurol 57:808-813, Elias,M.F.,et al, 2000

Reduced Prevalence of AD in Users of NSAIDs and H2 Receptor Antagonists
Neurol 54:2066-2071, Anthony,J.C.,et al, 2000

Stroke Knowledge Among Stroke Support Group Members
Stroke 31:1230-1233, Weltermann,B.M.,et al, 2000

A 5-Month, Randomized, Placebo-controlled Trial of Galantamine in AD
Neurol 54:2269-2276, Tariot,P.N.,et al, 2000

Galantamine in AD
Neurol 54:2261-2268, Raskind,M.A.,et al, 2000

Intravenous Tissue Plasminogen Activator for Acute Ischemic Stroke in Patients Aged 80 Years and Older, The tPa Stroke Survey Experience
Stroke 31:370-375, Tanne,D.,et al, 2000

Donepezil Therapy in Clinical Practice, A Randomized Crossover Study
Arch Neurol 57:94-99, Greenberg,S.M.,et al, 2000

Might Olfactory Dysfunction be a Marker of Early Alzheimer's Disease?
Lancet 355:84-85, Burns,A., 2000

Estrogen for Alzheimer's Disease in Women, Randomized, Double-Blind, Placebo-Controlled Trial
Neurol 54:295-301, Henderson,V.W.,et al, 2000

Transient Ischaemic Attack in a Young Woman
Lancet 355:622, Lee,P. & Tse, H., 2000

Stroke Treatment with Tissue Plasminogen Activator in the Setting of Aortic Dissection
Neurol 54:1010, Fessler,A.J. & Alberts,M.J., 2000

Neurological Emergencies: Acute Stroke
JNNP 68:277-288, Davenport,R. & Dennis,M., 2000

Intravenous Tissue-Type Plasminogen Activator for Treatment of Acute Stroke
JAMA 283:1145-1150,1189, Albers,G.W.,et al, 2000

Use of Tissue-Type Plasminogen Activator for Acute Ischemic Stroke
JAMA 283:1151-1158,1189, Katzan,I.L.,et al, 2000

An 80-Year-Old Man With Memory Loss
JAMA 283:1046-1053, Larson,E.B., 2000

Using Serial Registered Brain Magnetic Resonance Imaging to Measure Disease Progression in Alzheimer Disease
ArchNeurol 57:339-344, Fox,N.C.,et al, 2000

Diagnostic Accuracy of Dementia with Lewy Bodies
ArchNeurol 57:347-351, Hohl,U.,et al, 2000

Estrogen Replacement Therapy for Treatment of Mild to Moderate Alzheimer Disease
JAMA 283:1007-1015,1055, Mulnar,R.A.,et al, 2000

Cross Sectional Study of Reporting of Epileptic Seizures to General Practitioners
BMJ 320:94-97, Dalrymple,J. & Appleby,J., 2000

Cerebral Sinus Thrombosis Diagnosed by MRI and MR Venography in Cancer Patients
Neurol 54:1222-1226, Raizer,J.J.&DeAngelis,L.M., 2000

Decision Analysis and Guidelines for Anticoagulant Therapy to Prevent Stroke in Patients with Atrial Fibrillation
Lancet 355:956-962, Thomson,R.,et al, 2000

Progression of Parkinsonian Signs in Alzheimer's Disease
Neurol 54:1284-1289, Wilson,R.S.,et al, 2000

Outcome of Surgery for Thoracic Outlet Syndrome in Washington State Workers' Compensation
Neurol 54:1252-1257, Franklin,G.M.,et al, 2000

Stroke Prevention
Neurol 54:1899-1906, Holloway,R.G.,et al, 2000

Validity and Reliability of a Quantitative Computed Tomography Score in Predicting Outcome of Hyperacute Stroke Before Thrombolytic Therapy
Lancet 355:1670-1674, Barber,P.A.,et al, 2000

Smoking and Dementia in Male British Doctors: Prospective Study
BMJ 320:1097-1102,1087, Doll,R.,et al, 2000

Variability of the Mini-Mental State Examination in Dementia
Neurol 54:1538-1539, Doraiswamy,P.M.&Kaiser,L., 2000

Survival in End-Stage Dementia Following Acute Illness
JAMA 284: 47-52, 87, Morrison,R.S. & Siu,A.L., 2000

Treating Nondementia Illnesses in Patients With Dementia
JAMA 283:3230-3235, Brauner,D.J. et al, 2000

Intracranial Hemorrhage Associated With Thrombolytic Therapy for Eldery Patients With Acute Myocardial Infarction
Stroke 31:1802-1811, Brass,L.M. et al, 2000

Activation of Emergency Medical Services of Acute Stroke in a Nonurban Population
Stroke 31:1925-1928, Wein,T.H. et al, 2000

Patterns of Brain Activation in People at Risk for Alzheimer's Disease
NEJM 343:450-456,502, Bookheimer,S.Y. et al, 2000

Orolingual Angioneurotic Edema Following Therapy of Acute Ischemic Stroke with Alteplase
Neurol 55:599-600, Rudolf,J. et al, 2000

Relation Between Cholinesterase Inhibitor and Pisa Syndrome
Lancet 355:2222, Kwak,Y.T. et al, 2000



Showing articles 700 to 750 of 1454 << Previous Next >>